Therefore, targeting HCA2 and HCA3 would be beneficial in treating inflammation conditions associated with atherosclerosis and obesity-related adipose tissue inflammation. This evidence concerns the gene HCAR2 and obesity due to melanocortin 4 receptor deficiency.